PubRank

D De Lucia

Author PubWeight™ 11.89‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Inherited thrombophilic risk factors and venous thromboembolism: distinct role in peripheral deep venous thrombosis and pulmonary embolism. Chest 2000 1.60
2 Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins. JAMA 1999 1.42
3 Erectile and endothelial dysfunction in Type II diabetes: a possible link. Diabetologia 2001 1.02
4 Inherited prothrombotic conditions and premature ischemic stroke: sex difference in the association with factor V Leiden. Arterioscler Thromb Vasc Biol 1999 0.87
5 Glucose ingestion affects cardiac ANS in healthy subjects with different amounts of body fat. Am J Physiol 1997 0.81
6 Association of coagulation factor VArg506Gln mutation with non-insulin-dependent diabetes mellitus. Lancet 1996 0.81
7 Thromboelastographic profiles as a tool for thrombotic risk in digestive tract cancer. Exp Oncol 2007 0.81
8 Resistance to activated protein C in adults with a history of juvenile transient ischemic attacks. Thromb Haemost 1996 0.79
9 A G-to-A mutation in IVS-3 of the human gamma fibrinogen gene causing afibrinogenemia due to abnormal RNA splicing. Blood 2000 0.79
10 Association of primary antiphospholipid syndrome with inherited activated protein C resistance. J Rheumatol 1998 0.78
11 ACE gene polymorphism and insulin action in older subjects and healthy centenarians. J Am Geriatr Soc 2001 0.78
12 [Blood coagulation changes in patients with post-splenectomy persistent thrombocytosis]. Chir Ital 2001 0.78
13 Homozygous prothrombin gene mutation and ischemic cerebrovascular disease: a case report. Acta Haematol 1999 0.77
14 Short- and long-term treatments with iloprost in diabetic patients with peripheral vascular disease: effects on the cardiovascular risk factor plasminogen activator inhibitor type-1. Eur J Clin Pharmacol 1999 0.77
15 [A retrospective study of the serum CEA, AFP, TPA and ferritin values in 500 patients with chronic liver diseases]. Arch Monaldi Mal Torace 1993 0.75
16 [Haemocoagulative modifications correlated with pregnancy]. Minerva Ginecol 2006 0.75
17 A hypercoagulable state in activated protein C resistant patients with ischemic stroke. Int J Clin Lab Res 1998 0.75
18 Subcortical ischaemic changes in young hypertensive patients: frequency, effect on cognitive performance and relationship with markers of endothelial and haemostatic activation. Eur J Neurol 2007 0.75
19 [Hypersensitivity to oral anticoagulants: report of a case]. Ital Heart J Suppl 2001 0.75
20 High prevalence of activated protein C resistance in patients with systemic sclerosis. Int J Clin Lab Res 1995 0.75
21 Regenerated EDL muscle of rats requires innervation to maintain AChE molecular forms. Muscle Nerve 1990 0.75
22 Helicobacter pylori infection and the risk of myocardial infarction: role of fibrinogen and its genetic control. Thromb Haemost 1999 0.75
23 [Thrombophilic syndrome associated to phenotypic resistance to activated protein C in postmenopausal women]. Minerva Ginecol 2004 0.75
24 Evaluation of genotyping methods and costs for VDR polymorphisms. Eur Rev Med Pharmacol Sci 2017 0.75
25 [The effects of phytoestrogen therapy on the endometrium in postmenopausal women]. Minerva Ginecol 2005 0.75
26 Coagulation derangements in oral and maxillofacial surgery in patients with a documented cancer: a follow-up study after surgery. J Dent Res 2003 0.75
27 [Hypercoagulability during pregnancy: evidences for a thrombophilic state]. Minerva Ginecol 2006 0.75
28 Analysis of three genetic polymorphisms as risk factors for thrombosis. Int J Clin Lab Res 1999 0.75
29 [Diagnostic contribution of serum levels of tumor markers in adenocarcinoma of the breast]. J Nucl Med Allied Sci 1991 0.75
30 [The CA 19-9, CA 125, CA 72-4 and CA 50 tumor markers in neoplastic disease: results of a 3-year experience]. J Nucl Med Allied Sci 1991 0.75
31 Reversible adult respiratory distress in primary antiphospholipid syndrome. Haematologica 2000 0.75